Refine Search
(24)
(319)
(846)
(1727)

Glaucoma: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people...

Cloud Computing in Healthcare - Thematic Research

  • $1,950
  • December 2018
Add to Basket Quick View Add to Saved List

Cloud computing (including IaaS, PaaS, SaaS, private, and hybrid cloud services, managed cloud services and cloud management platforms) accounted for 7.6% of a global information and communications technology (ICT) market that was worth $3 tril...

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition

  • $4,995
  • December 2018
Add to Basket Quick View Add to Saved List

Biosimilars are drugs that are highly similar but not identical to branded “innovator” biologics: large molecule, immunogenic drugs produced from living cells. “Innovator” biologics are the first to be approved, and when their patent protection...

Contraceptives: Opportunity Analysis and Forecasts to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Hormonal contraceptives are primarily used to prevent unintended pregnancy; however, some of these contraceptives are also approved or used off-label for other health conditions, particularly menstrual-related disorders. This report focuses on ...

Biomarkers and Companion Diagnostics in Oncology

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

A biomarker is a defined molecular characteristic, for example a genetic mutation, that can tell a physician more about a patient’s disease state, or how they might respond to treatment. Predictive biomarkers indicate how likely a patient is to...

Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

Emerging infectious diseases (EIDs) are characterized by unpredictable incidence and clinical patterns that pose unique challenges for vaccine development. As outbreaks of Ebola virus, Zika virus, and other EIDs have occurred in the past decade...

Neuroimmunology Drug Development

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

Neuroimmunology is expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in neurogenetics, and potential of these drugs that can contri...

Partnerships, Licensing, Investments and M&A Deals and Trends for September 2018 in Pharmaceuticals

  • $1,000
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for September 2018 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) ...

Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals

  • $1,000
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) an...

Botulism Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Botulism Global Clinical Trials Review, H2, 2018" provides an overview of Botulism clinical trials scenario. This report provides top line data relating to the clinical trials on Botulism. Report in...

Bradycardia Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bradycardia Global Clinical Trials Review, H2, 2018" provides an overview of Bradycardia clinical trials scenario. This report provides top line data relating to the clinical trials on Bradycardia. ...

Brain Cancer Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cance...

Brain (Head) Trauma Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain (Head) Trauma Global Clinical Trials Review, H2, 2018" provides an overview of Brain (Head) Trauma clinical trials scenario. This report provides top line data relating to the clinical trials ...

Brain Hemorrhage Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H2, 2018" provides an overview of Brain Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Bra...

Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018" provides an overview of Branch Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to ...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks